• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

COVID-19 Treatment 
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for COVID-19 treatment trials.

DOWNLOAD BROCHURE GET IN TOUCH

Effective solutions for advancing COVID-19 treatment research

Schizophrenia is a leading cause of patient suffering and disability around the world. Despite the compelling, unmet need for new and more effective treatments, the development process remains challenging. At Signant, we offer study sponsors a team with the scientific expertise and global experience, as well as innovative technology, to help run successful schizophrenia trials. Leverage our Signant SmartSignals suite to help your adult or pediatric trial succeed.

Covid Treatment-1

Why Signant Health

  • Accelerate Trials
  • Retire Error-Prone Paper Processes
  • Scale Clinical Operations Globally
  • Collaborate with our Experts
  • Streamline Data Management
  • Accelerate Trials

    Accelerate Trials

    Researchers around the world are continuing to identify new ways to treat and prevent COVID-19. Signant’s eConsent, RTSM, and eCOA solutions speed up studies and increase data accuracy to help you reach conclusions about treatment efficacy faster.

     

  • Retire Error-Prone Paper Processes

    Retire Error-Prone Paper Processes

    The coronavirus pandemic proved to our industry that pencil and paper are not conducive to decentralized, global trials. Signant’s eConsent and eCOA solutions reduce errors and increase data reliability in COVID-19 treatment studies. Combine them with RTSM and Telemedicine for fully digitized study processes that reduce burdens on sponsors, sites, and patients.

  • Scale Clinical Operations Globally

    Scale Clinical Operations Globally

    With participant populations and sites scattered around the globe, you will need tools and expertise to handle the logistics of a geographically dispersed study. We help manage complexities with solutions such as telemedicine, eCOA, and RTSM so you can focus on your study endpoints.
     

  • Collaborate with our Experts

    Collaborate with our Experts

    Leverage Signant’s science and medicine team can for provide guidance on all areas of trial design and conduct. From patient engagement to site monitoring and eCOA strategy, we help generate the accurate endpoint data you need for regulatory submission.
     

  • Streamline Data Management

    Streamline Data Management

    Access your study data when and how you need it. With our data management services, you can collect, review, clean, and migrate clinical data as your protocol requires. From audit trail logs to change authorizations and database locks/archiving, our systems and services also facilitate seamlessly moving between study phases following adaptive design decision points.
     

Comprehensive COVID-19 Treatment experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our COVID-19 treatment trial resources
SOLUTION BROCHURE

COVID-19 Treatment Trial Solutions Overview



GET INSIGHTS
VIDEO

COVID-19 Treatment Trial Solutions



WATCH [2 MIN]
CASE STUDY

Signant Collaborates with Clinical Trial Payments Solution Provider For High-Profile Vaccine Study 

 
READ CASE STUDY

eClinical solutions for COVID-19 Treatment trials

Ready to learn more?

Discover how Signant can support your current or upcoming coronavirus treatment trials. 

DOWNLOAD BROCHURE GET STARTED